Western and Sumagen to release preliminary results from HIV/AIDS vaccine trials

Print

By Communications Staff
Monday, November 5, 2012
WHAT: Western University and Sumagen Canada will hold a briefing for media and London's research community regarding preliminary results for the first-ever human applied clinical study (SAV CT 01) of the world's only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H), which was initiated in March 2012.
 
Last year, SAV001-H received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.

http://communications.uwo.ca/media/hivvaccine/

WHEN: Tuesday, November 6, 2012 at 11 a.m.

WHERE: Siebens Drake Research Institute, Room 217, Western University, London, Ontario

WHO: Dr. Chil-Yong Kang of Western's Schulich School of Medicine & Dentistry and Dr. Dong Joon Kim of Sumagen Co. Ltd.

Media is advised parking is available at Dental Parking Lot (C) and Social Science Lot (J).

http://www.uwo.ca/parking/parkingmap.pdf

MEDIA CONTACT: Jeff Renaud, Senior Media Relations Officer, 519-661-2111, ext. 85165, jrenaud9@uwo.ca

 

 

 

 

 

 

 

 

 

 

 

 

 

Media Relations team

Keith Marnoch
Director, Media Relations
519-661-2111 x85468
kmarnoch@uwo.ca

Jeff Renaud
Senior Media Relations Officer
519-661-2111, ext. 85165
jrenaud9@uwo.ca

Susanna Eayrs

Communications Officer
Law
519-661-2126
seayrs@uwo.ca

Kathy Wallis

Media Relations Officer
Medicine & Dentistry Robarts Research Institute
519-661-2111, ext. 81136
kathy.wallis@ schulich.uwo.ca

Douglas Keddy

Research Communications Manager
Research Western
519-661-2111, ext. 87485
dkeddy@uwo.ca

Ivan Langrish
Senior Manager, Media Strategy Richard Ivey School of Business
416-203-0664
ilangrish@ivey.uwo.ca

 

Subscribe to the RSS Feed

RSS Button Media Releases Feed
About this Feed
 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

Western provides the best student experience among Canada's leading research-intensive universities.